...
首页> 外文期刊>Journal of Medicinal Chemistry >Atropisomerism by Design: Discovery of a Selective and Stable Phosphoinositide 3-Kinase (PI3K) beta Inhibitor
【24h】

Atropisomerism by Design: Discovery of a Selective and Stable Phosphoinositide 3-Kinase (PI3K) beta Inhibitor

机译:通过设计的阿比托主义:发现选择性稳定的磷酸阳性3-激酶(PI3K)β抑制剂

获取原文
获取原文并翻译 | 示例
           

摘要

Atropisomerism is a type of axial chirality in which enantiomers or diastereoisomers arise due to hindered rotation around a bond axis. In this manuscript, we report a case in which torsional scan studies guided the thoughtful creation of a restricted axis of rotation between two heteroaromatic systems of a phosphoinositide 3-kinase (PI3K) beta inhibitor, generating a pair of atropisomeric compounds with significantly different pharmacological and pharmacokinetic profiles. Emblematic of these differences, the metabolism of inactive (M)-28 is primarily due to the cytosolic enzyme aldehyde oxidase, while active (P)-28 has lower affinity for aldehyde oxidase, resulting in substantially better metabolic stability. Additionally, we report torsional scan and experimental studies used to determine the barriers of rotation of this novel PI3K beta inhibitor.
机译:无制剂是一种轴向手性,其中映异构体或非映异构体由于围绕粘结轴线妨碍旋转而产生。 在这一稿件中,我们报告了扭转扫描研究引导了磷酸阳性3-激酶(PI3K)β抑制剂的两个杂芳族体系之间的限制旋转轴的周到创造的情况,产生一对具有显着不同药理学和药理学和药物和 药代动力学曲线。 这些差异的象征性,无活性(M)-28的代谢主要是由于胞质酶醛氧化酶,而活性(P)-28对醛氧化酶具有较低的亲和力,导致基本上更好的代谢稳定性。 此外,我们报告扭转扫描和实验研究,用于确定该新型PI3Kβ抑制剂的旋转障碍。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号